New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies

Affiliations

¹ Departament of Nephrology, Jagiellonian University Medical College, 31-008 Cracow, Poland.
² John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA.
³ Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, 02-091 Warszawa, Poland.
⁴ Departament of Hematology, Jagiellonian University Medical College, 31-008 Cracow, Poland.
⁵ Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok 15-276 Białystok, Poland.
⁶ Departament of Nephrology, Medical University, 15-089 Bialystok, Poland.
⁷ Department of Clinical Medicine, Medical University of Bialystok, 15-254 Bialystok, Poland.
⁸ Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.

Review

Karolina Woziwodzka et al. J Clin Med. 2020.

. 2020 May 31;9(6):1652.

doi: 10.3390/jcm9061652.

¹ Departament of Nephrology, Jagiellonian University Medical College, 31-008 Cracow, Poland.
² John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA.
³ Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, 02-091 Warszawa, Poland.
⁴ Departament of Hematology, Jagiellonian University Medical College, 31-008 Cracow, Poland.
⁵ Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok 15-276 Białystok, Poland.
⁶ Departament of Nephrology, Medical University, 15-089 Bialystok, Poland.
⁷ Department of Clinical Medicine, Medical University of Bialystok, 15-254 Bialystok, Poland.
⁸ Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.

Abstract

* Correspondence: kasiajanda@op [...].

The authors declare no conflict of interest.

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA. Cancer J. Clin. 2019;69:7–34. doi: 10.3322/caac.21551. - DOI - PubMed
1. Kyle R.A., Larson D.R., Therneau T.M., Dispenzieri A., Kumar S., Cerhan J.R., Rajkumar S.V. Long-term follow-up of monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 2018;378:241–249. doi: 10.1056/NEJMoa1709974. - DOI - PMC - PubMed
1. Kyle R.A., Gertz M.A., Witzig T.E., Lust J.A., Lacy M.Q., Dispenzieri A., Fonseca R., Rajkumar S.V., Offord J.R., Larson D.R., et al. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma. Mayo Clin. Proc. 2003;78:21–33. doi: 10.4065/78.1.21. - DOI - PubMed
1. Małgorzata B., Jolanta M., David H.V., Karolina W., Artur J., Marcin Ż., Marcin K., Jacek M., Krzysztof B., Marek K., et al. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia. J. Clin. Med. 2019;8:1828. - PMC - PubMed
1. Knudsen L.M., Hippe E., Hjorth M., Holmberg E., Westin J. Renal function in newly diagnosed multiple myeloma—A demographic study of 1353 patients. Eur. J. Haematol. 1994;53:207–212. doi: 10.1111/j.1600-0609.1994.tb00190.x. - DOI - PubMed